79 related articles for article (PubMed ID: 29183000)
1. The lymphatics in infiltrating ductal carcinoma (IDC) of the breast.
van Netten JP; Cann SH; Thornton IG; Finegan RP
Cancer Treat Rev; 2018 Jan; 62():97. PubMed ID: 29183000
[No Abstract] [Full Text] [Related]
2. The role of micronucleus scoring in fine needle aspirates of ductal carcinoma of the breast.
Samanta S; Dey P; Nijhawan R
Cytopathology; 2011 Apr; 22(2):111-4. PubMed ID: 20553316
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the intra-vessel tumor characteristics of invasive ductal carcinoma of the breast: a prospective study.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Virchows Arch; 2004 Jan; 444(1):20-7. PubMed ID: 14624360
[TBL] [Abstract][Full Text] [Related]
4. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
[TBL] [Abstract][Full Text] [Related]
6. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
[TBL] [Abstract][Full Text] [Related]
7. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
8. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].
Paumier A; Sagan C; Campion L; Fiche M; Andrieux N; Dravet F; Pioud R; Classe JM
J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):529-34. PubMed ID: 14593298
[TBL] [Abstract][Full Text] [Related]
9. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
[TBL] [Abstract][Full Text] [Related]
10. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological correlation of cutaneous metastatic breast carcinoma using lymphatic and vascular markers: lymphatics are mainly involved in cutaneous metastasis.
Yun SJ; Park HY; Lee JS; Park MH; Lee JB; Won YH
Clin Exp Dermatol; 2012 Oct; 37(7):744-8. PubMed ID: 22329727
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient value of diffusion-weighted imaging for differential diagnosis of ductal carcinoma in situ and infiltrating ductal carcinoma.
Ding JR; Wang DN; Pan JL
J Cancer Res Ther; 2016; 12(2):744-50. PubMed ID: 27461644
[TBL] [Abstract][Full Text] [Related]
13. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
14. A case of renal cell carcinoma metastasizing to invasive ductal breast carcinoma.
Chen TD; Lee LY
J Formos Med Assoc; 2014 Feb; 113(2):133-6. PubMed ID: 24530247
[TBL] [Abstract][Full Text] [Related]
15. Infiltrating ductal carcinoma of the breast: extensive intraductal component has no impact on lymph node involvement and survival.
Joura EA; Lösch A; Kainz C; Sam C; Joura EM; Gitsch G; Dadak C; Breitenecker G
Anticancer Res; 1995; 15(5B):2285-6. PubMed ID: 8572638
[TBL] [Abstract][Full Text] [Related]
16. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
17. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
18. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion.
Maluf H; Koerner F
Int J Surg Pathol; 2001 Apr; 9(2):127-31. PubMed ID: 11484500
[TBL] [Abstract][Full Text] [Related]
19. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
